68Ga-PSMA-11 PET/CT has shown notable specificity and sensitivity in the diagnosis and staging of primary prostate cancer, re-staging of patients with recurrent prostate cancer (PCa), and evaluating castration-resistant prostate cancer (CRPC). This evidence concerns the gene FOLH1 and prostate cancer.